MARKETWIRE.NET

Decode Your Next Market Move

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Gold Nanoparticles market. Market segmentation includes Type (Water Soluble, Oil Soluble and Other Types) and End-Use (Healthcare, Electronics, Catalytic Activity and Other End-Uses).

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

24 November 4:22 a.m., Silicon Valley, California - According to the new market research report, the global market for Gold Nanoparticles is projected to grow at a CAGR of 11.9% reach US$7.6 billion by 2027, driven advancements in the area of nanotechnology, its growing use in the field of medicine, diagnostics and target imaging.
Opportunities in the gold nanoparticles market continue to emerge in new application verticals such as target imaging for cancer therapy and dental filling in dentistry. The global Gold Nanoparticles market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Gold nanoparticles are already being widely used in a broad range of biomedical and healthcare applications. The use of gold nanoparticles is now being studied for fighting against coronavirus. Gold nanoparticles (GNPs or AuNPs) refer to gold particles with diameter in the range of 1-100 nanometers (nm). Gold nanoparticles are produced in the form of nanocages, nanospheres, nanorods, nanoclusters, nanoshells, and nanocubes, and are typically characterized by large surface area, high electron conductivity, bio-inertness, stability, and superior solubility features. Gold nanoparticles are employed in different applications such as catalysis, probes, sensors, therapeutic agent delivery, photodynamic therapy, and electronics.

Gold nanoparticles are anticipated to play an important role in enabling a comprehensive array of research and novel applications in diverse domains. Gold nanoparticles, owing to their high biocompatibility, rich surface chemistry, and unique optical properties, have attracted significant attention from the biomedical and material science community in recent years. Though colloid gold has been in use for a wide range of therapeutic applications for past many decades, recent developments in reliably synthesizing gold nanoparticles of various sizes and shapes at scale has resulted in a burst of research activity related to their biomedical applications, including diagnostic testing and medical procedures and treatments. Gold nanoparticles are widely recognized in the field of therapeutics owing their unique shape and size, presenting new avenues for combinational cancer therapies. The scientific community is increasingly targeting gold nanoparticles due to their morphology- and size-dependent electrical, physical, chemical and optical properties. These nanoparticles hold an extensive spectrum of useful applications in optoelectronics, nanoelectronics, biological and chemical sensors. Researchers continue to exploit different techniques to synthesize gold nanoparticles owing to their shape- and size-dependent properties. Gold nanoparticles also hold tremendous potential for numerous biomedical applications including bio-imaging, biosensors, controlled drug release and targeted drug delivery. Gold nanoparticles exhibit superior sensitivity and selectivity related to colorimetric identification of specific heavy toxic metal ions and several biomolecules. The integration of gold nanoparticles is likely to boost efficiency of solar cells for enhanced output, while novel biomedical applications present new opportunities for treatment of several types of cancer including breast cancer, adenocarcinoma, gastric, melanoma, lung, laryngeal, prostate and oral cancer. These nanoparticles are expected to favor therapeutics and medical diagnostics, improve disease specificity, and allow targeted drug delivery in a more cost-efficient manner in comparison to the available standard chemotherapeutic options.

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 469. Among this pool, 94 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 19 unique participations, a total of 9 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.

Key Competitors Covered in the Report -
American Elements
Abcam PLC
Cosmo Bio Co., Ltd.
BBI Solutions
Blacktrace Holdings Ltd.
Creative Diagnostics
Cline Scientific AB
Cytodiagnostics Inc.
Hongwu International Group Ltd.
4Basebio

Segments Covered in the Report -
Type (Water Soluble, Oil Soluble, Other Types)
End-Use (Healthcare, Electronics, Catalytic Activity, Other End-Uses)

Geographies Analyzed in the Report -
World
USA
Canada
Japan
China
Europe
France
Germany
Italy
UK
Rest of Europe
Asia-Pacific
Rest of World.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com